Basic Information
RNALocate ID: | RLID:11000826 |
RNA Symbol: | hsa-miR-24-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-24 |
RNA ID: | miRBase:MIMAT0000080 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001331 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001332 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001333 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001334 | Mitochondrion | Myotube | 27396686 |
RLID:01001335 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001336 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001337 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001338 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001339 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11000823 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11000824 | Exosome | Sera | 24978137 |
RLID:11000825 | Exosome | Pooled sera | 27278097 |
RLID:11000827 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000828 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11000829 | Exosome | Plasma | 23663360 |
RLID:11000830 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000831 | Microvesicle | Plasma | 23077538 |
RLID:11000832 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000833 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000834 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000016 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Seminal fluid|Tongue tissue | |
RLID-D:11000279 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-24-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-32530 |
MNDR | hsa-miR-24-3p | Colorectal adenocarcinoma | MNDR-E-MI-32531 |
MNDR | hsa-miR-24-3p | Tongue squamous cell carcinoma | MNDR-E-MI-32532 |
MNDR | hsa-miR-24-3p | Oral squamous cell carcinoma | MNDR-E-MI-32533 |
MNDR | hsa-miR-24-3p | Medulloblastoma | MNDR-E-MI-32534 |
MNDR | hsa-miR-24-3p | B cell lymphoma of malt type | MNDR-E-MI-32535 |
MNDR | hsa-miR-24-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-32536 |
MNDR | hsa-miR-24-3p | Lymphoma | MNDR-E-MI-32537 |
MNDR | hsa-miR-24-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-32538 |
MNDR | hsa-miR-24-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-32539 |
MNDR | hsa-miR-24-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-32540 |
MNDR | hsa-miR-24-3p | Her2-receptor positive breast cancer | MNDR-E-MI-32541 |
MNDR | hsa-miR-24-3p | Breast cancer luminal | MNDR-E-MI-32542 |
MNDR | hsa-miR-24-3p | Anencephaly | MNDR-E-MI-32543 |
MNDR | hsa-miR-24-3p | Niemann-pick disease type c | MNDR-E-MI-32544 |
MNDR | hsa-miR-24-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-32545 |
MNDR | hsa-miR-24-3p | Osteomyelitis | MNDR-E-MI-32546 |
MNDR | hsa-miR-24-3p | Dermatomyositis | MNDR-E-MI-32547 |
MNDR | hsa-miR-24-3p | Prostate cancer | MNDR-E-MI-32548 |
MNDR | hsa-miR-24-3p | Gastric cancer | MNDR-E-MI-32549 |
MNDR | hsa-miR-24-3p | Alzheimer disease | MNDR-E-MI-32550 |
MNDR | hsa-miR-24-3p | Intracranial aneurysm | MNDR-E-MI-32551 |
MNDR | hsa-miR-24-3p | Bladder cancer | MNDR-E-MI-32552 |
MNDR | hsa-miR-24-3p | Esophageal carcinoma | MNDR-E-MI-32553 |
MNDR | hsa-miR-24-3p | Dysautonomia familial | MNDR-E-MI-32554 |
MNDR | hsa-miR-24-3p | Cardiovascular disease | MNDR-E-MI-32555 |
MNDR | hsa-miR-24-3p | Carotid stenosis | MNDR-E-MI-32556 |
MNDR | hsa-miR-24-3p | Lung cancer | MNDR-E-MI-32557 |
MNDR | hsa-miR-24-3p | Down syndrome | MNDR-E-MI-32558 |
MNDR | hsa-miR-24-3p | Parkinson disease | MNDR-E-MI-32559 |
MNDR | hsa-miR-24-3p | Niemann-pick disease | MNDR-E-MI-32560 |
MNDR | hsa-miR-24-3p | Basal-like breast cancer | MNDR-E-MI-32561 |
MNDR | hsa-miR-24-3p | Thyroid cancer | MNDR-E-MI-32562 |
MNDR | hsa-miR-24-3p | Pituitary neoplasms | MNDR-E-MI-32563 |
MNDR | hsa-miR-24-3p | Pancreatic cancer | MNDR-E-MI-32564 |
MNDR | hsa-miR-24-3p | Melanoma | MNDR-E-MI-32565 |
MNDR | hsa-miR-24-3p | Rectum adenocarcinoma | MNDR-E-MI-32566 |
MNDR | hsa-miR-24-3p | Colon cancer | MNDR-E-MI-32567 |
MNDR | hsa-miR-24-3p | Ischemic attack transient | MNDR-E-MI-32568 |
MNDR | hsa-miR-24-3p | Colon adenocarcinoma | MNDR-E-MI-32569 |
MNDR | hsa-miR-24-3p | West nile virus infection | MNDR-E-MI-32570 |
MNDR | hsa-miR-24-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-32571 |
MNDR | hsa-miR-24-3p | Familial ovarian cancer | MNDR-E-MI-32572 |
MNDR | hsa-miR-24-3p | Prostate adenocarcinoma | MNDR-E-MI-32573 |
MNDR | hsa-miR-24-3p | Laryngeal squamous cell carcinoma | MNDR-E-MI-32574 |
MNDR | hsa-miR-24-3p | Invasive ductal carcinoma | MNDR-E-MI-32575 |
MNDR | hsa-miR-24-3p | Glioblastoma | MNDR-E-MI-32576 |
MNDR | hsa-miR-24-3p | Astrocytoma | MNDR-E-MI-32577 |
MNDR | hsa-miR-24-3p | Glioma | MNDR-E-MI-32578 |
MNDR | hsa-miR-24-3p | Chronic obstructive pulmonary disease | MNDR-E-MI-32579 |
MNDR | hsa-miR-24-3p | Chordoma | MNDR-E-MI-32580 |
MNDR | hsa-miR-24-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-32581 |
MNDR | hsa-miR-24-3p | Osteosarcoma | MNDR-E-MI-32582 |
MNDR | hsa-miR-24-3p | Liposarcoma | MNDR-E-MI-32583 |
MNDR | hsa-miR-24-3p | Coronary artery disease | MNDR-E-MI-32584 |
MNDR | hsa-miR-24-3p | Inclusion body myositis | MNDR-E-MI-32585 |
MNDR | hsa-miR-24-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-32586 |
MNDR | hsa-miR-24-3p | Meningioma | MNDR-E-MI-32587 |
MNDR | hsa-miR-24-3p | Liver cancer | MNDR-E-MI-32588 |
MNDR | hsa-miR-24-3p | Uterine cancer | MNDR-E-MI-32589 |
MNDR | hsa-miR-24-3p | Cervical squamous cell carcinoma | MNDR-E-MI-32590 |
MNDR | hsa-miR-24-3p | Pituitary adenoma | MNDR-E-MI-32591 |
MNDR | hsa-miR-24-3p | Lung squamous cell carcinoma | MNDR-E-MI-32592 |
MNDR | hsa-miR-24-3p | Lung adenocarcinoma | MNDR-E-MI-32593 |
MNDR | hsa-miR-24-3p | Thyroid carcinoma | MNDR-E-MI-32594 |
MNDR | hsa-miR-24-3p | Ovarian carcinoma | MNDR-E-MI-32595 |
MNDR | hsa-miR-24-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-32596 |
MNDR | hsa-miR-24-3p | Carcinoma renal cell | MNDR-E-MI-32597 |
MNDR | hsa-miR-24-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-32598 |
MNDR | hsa-miR-24-3p | Clear cell renal cell carcinoma | MNDR-E-MI-32599 |
MNDR | hsa-miR-24-3p | Biliary tract cancer | MNDR-E-MI-32600 |
MNDR | hsa-miR-24-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-32601 |
MNDR | hsa-miR-24-3p | Cholangiocarcinoma | MNDR-E-MI-32602 |
MNDR | hsa-miR-24-3p | Pancreatitis | MNDR-E-MI-32603 |
MNDR | hsa-miR-24-3p | Esophageal cancer | MNDR-E-MI-32604 |
MNDR | hsa-miR-24-3p | Liver cirrhosis | MNDR-E-MI-32605 |
MNDR | hsa-miR-24-3p | Lung small cell carcinoma | MNDR-E-MI-32606 |
MNDR | hsa-miR-24-3p | Schizophrenia | MNDR-E-MI-32607 |
MNDR | hsa-miR-24-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-32608 |
MNDR | hsa-miR-24-3p | Heart failure | MNDR-E-MI-32609 |
MNDR | hsa-miR-24-3p | Encephalomyelitis | MNDR-E-MI-32610 |
MNDR | hsa-miR-24-3p | Early hepatocellular carcinoma | MNDR-E-MI-32611 |
MNDR | hsa-miR-24-3p | Familiar ovarian carcinoma | MNDR-E-MI-32612 |
MNDR | hsa-miR-24-3p | B-cell lymphoma | MNDR-E-MI-32613 |
MNDR | hsa-miR-24-3p | Rheumatoid arthritis | MNDR-E-MI-32614 |
MNDR | hsa-miR-24-3p | Barrett's adenocarcinoma | MNDR-E-MI-32615 |
MNDR | hsa-miR-24-3p | Hodgkin lymphoma | MNDR-E-MI-32616 |
MNDR | hsa-miR-24-3p | Ulcerative colitis | MNDR-E-MI-32617 |
MNDR | hsa-miR-24-3p | Burkitt lymphoma | MNDR-E-MI-32618 |
MNDR | hsa-miR-24-3p | Acute myelocytic leukemia | MNDR-E-MI-32619 |
MNDR | hsa-miR-24-3p | Colorectal cancer | MNDR-E-MI-32620 |
MNDR | hsa-miR-24-3p | Nasopharynx carcinoma | MNDR-E-MI-32621 |
MNDR | hsa-miR-24-3p | Type 2 diabetes mellitus | MNDR-E-MI-32622 |
MNDR | hsa-miR-24-3p | Multiple myeloma | MNDR-E-MI-32623 |
MNDR | hsa-miR-24-3p | Leukemia lymphoblastic acute | MNDR-E-MI-32624 |
MNDR | hsa-miR-24-3p | Ependymoma | MNDR-E-MI-32625 |
MNDR | hsa-miR-24-3p | Hearing loss noise-induced | MNDR-E-MI-32626 |
MNDR | hsa-miR-24-3p | Cardiac hypertrophy | MNDR-E-MI-32627 |
MNDR | hsa-miR-24-3p | Nasopharyngeal cancer | MNDR-E-MI-32628 |
MNDR | hsa-miR-24-3p | Prostatic neoplasms | MNDR-E-MI-32629 |
MNDR | hsa-miR-24-3p | Sleep deprivation | MNDR-E-MI-32630 |
MNDR | hsa-miR-24-3p | Hypersomnolence idiopathic | MNDR-E-MI-32631 |
MNDR | hsa-miR-24-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-32632 |
MNDR | hsa-miR-24-3p | Vesicular stomatitis | MNDR-E-MI-32633 |
MNDR | hsa-miR-24-3p | Sarcopenia | MNDR-E-MI-32634 |
MNDR | hsa-miR-24-3p | Stroke lacunar | MNDR-E-MI-32635 |
MNDR | hsa-miR-24-3p | Barrett's carcinogenesis | MNDR-E-MI-32636 |
MNDR | hsa-miR-24-3p | Breast cancer her3+ negative | MNDR-E-MI-32637 |
MNDR | hsa-miR-24-3p | High grade dysplastic nodule | MNDR-E-MI-32638 |
MNDR | hsa-miR-24-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-32639 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB9 | Homo sapiens | RR00023201 |
TOP